Alaunos Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.63

+0.29 (+12.39%)

As of Feb 8, 2:31 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +1,460.1% upside

Low Target $36.60

Average Target $41.03

High Target $68.97

Current Price $2.63

Current
$2.63

Target
$41.03

$36.60 $41.03 avg $68.97

Scenario Analysis

Bear Case

$36.60

1,291.6%

Low target

Base Case

$41.03

+1,460.1%

Avg target

Bull Case

$68.97

+2,522.4%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$47.52

-94.5% from high

52-Week Low

$27.38

+-90.4% from low

Target vs 52W High

$41.03

-13.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%